Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

MIMA deliver stereotactic body radiotherapy to treat soft tissue carcinoma

Varian : 23 July, 2008  (Application Story)
Doctors at Melbourne Internal Medical Associates (MIMA) Cancer Center have become the first in the world to treat cancer use RapidArc radiotherapy technology from Varian Medical Systems to deliver stereotactic body radiotherapy (SBRT) in the treatment of soft tissue carcinoma.
A 72-year-old man with Merkel cell carcinoma was treated for a soft tissue tumour in his thigh, which had developed close to where a similar tumour had been treated with conventional Radiotherapy six months earlier.

'In this case, it was important that we avoid exposing the previously-treated area to any additional radiation,' said Todd Scarbrough, MD, radiation oncologist and director of the MIMA Cancer Center. 'Using RapidArc, we completed each of his treatment sessions in just five minutes, including imaging and treatment. In the past, using conventional IMRT, this type of treatment would have required 30 minutes per session to complete.'

RapidArc makes it possible to quickly deliver an advanced image-guided, intensity-modulated radiation therapy (IMRT) treatment with one 360 degree rotation of the treatment machine around the patient. In this case, however, Scarbrough and his team designed a treatment that was delivered with just half a rotation around the patient.

'The tumour was near the surface of his thigh, so a full arc would have exposed too much of his normal leg to the treatment beam,' Scarbrough said.

Scarbrough's team planned the RapidArc treatment using Varian's Eclipse treatment planning software, which allowed them to visualise how the dose would be distributed within the patient's leg.

'The RapidArc plan gave us a dose distribution that was superior to what we could have achieved with traditional IMRT,' Scarbrough said. 'Eclipse made it easy to create a plan that would avoid the previously-irradiated tissues. We just superimposed the dose distribution from his earlier treatments onto the new CT scans, created a structure out of that area, and instructed the software to avoid it as if it were a critical organ. It was very easy to do.'

Stereotactic body Radiotherapy involves delivering higher-than-usual doses of radiation to a tumor over a shorter-than-usual timeframe. It requires great accuracy and precision, both in terms of targeting and in terms of beam shaping, to minimize the exposure of surrounding tissues. MIMA's RapidArc protocol achieves the necessary level of precision. 3-D X-ray images of the targeted area are used to fine-tune patient positioning prior to each treatment. Then, as the treatment machine rotates around the patient, the treatment beam is continually shaped and reshaped to match the dimensions of the tumour.

'Any time you have a spherical lesion that is deep within the body, and you want to deliver a high dose, RapidArc is going to be the ideal way to treat,' Scarbrough said. 'Our plan is to use RapidArc any time the treatment plan gives us a dose distribution that is equal to or better than what we can get with standard IMRT, because RapidArc is so much faster. And that's much better for our patients.'
Scarbrough's team is now working on RapidArc treatment plans for a prostate and a lung cancer case scheduled to begin treatment later this month.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo